申请人:Cerulean Pharma Inc.
公开号:EP3566719A1
公开(公告)日:2019-11-13
Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
本文提供了有关使用 CDP-治疗剂共轭物治疗自身免疫性疾病、炎症性疾病或癌症的方法。还提供了 CDP-治疗剂共轭物、包含 CDP-治疗剂共轭物的颗粒和包含 CDP-治疗剂共轭物的组合物。